Sfoglia per Autore
Eculizumab as a Disease-Modifying Therapy in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): A Case Report
2025 Schilke, E; Cereda, D; Fusco, M; Stanzani, L; Marzorati, L; Ripolone, M; Bertolasi, L; Frigo, M; Molteni, F; Farina, N; Ferrarese, C; Cavaletti, G; Balducci, C
Pharmacodynamic Drug-Drug Interaction Between Oxaliplatin and HDAC Inhibitors in Colorectal Cancer Cell Lines
2024 Squarzoni, A; Ette, M; Boleslav, B; Donzelli, E; Scuteri, A; Cavaletti, G; Donald, M
Dorsal Root Ganglia Neurons Morphometry Analysing Method Optimization
2024 Invernizzi, C; Capelli, C; Pozzi, E; Canta, A; Chiorazzi, A; Ballarini, E; Rodriguez Menendez, V; Cavaletti, G; Alberti, P
Oxaliplatin-induced peripheral neurotoxicity: molecular insights
2024 Alberti, P; Pozzi, E; Serra, M; Trucas, M; Boi, M; Capelli, C; Invernizzi, C; Chiorazzi, A; Ballarini, E; Rodriguez-Menendez, V; Quartu, M; Cavaletti, G
CENTRAL AND PERIPHERAL MICROVASCULAR NETWORK IS ABNORMAL IN RATS WITH PAINFUL-CHEMOTHERAPY INDUCED NEUROPATHY: NEW PATHOPHYSIOLOGICAL MECHANISMS OVER THE HORIZON?
2024 Carozzi, V; Rodriguez-Menendez, V; Pozzi, E; Canta, A; Chiorazzi, A; Cordani, N; Alberti, P; Meregalli, C; Longo, E; Saccomano, G; Tromba, G; Donà, E; Cavaletti, G; Zippo, A
EVALUATION OF SATELLITE GLIAL CELLS CHANGES IN DORSAL ROOT GANGLIA IN CHEMOTHERAPY-INDUCED NEUROTOXICITY MODELS
2024 Pozzi, E; Rodriguez-Menendez, V; Argentini, A; Canta, A; Alberti, P; Meregalli, C; Cherchi, L; Cavaletti, G; Carozzi, V
Histone deacetylase 6 inhibitors and neuroprotection: evidences and molecular mechanisms
2024 Squarzoni, A; Donzelli, E; Rodriguez-Menendez, V; Cavaletti, G; Scuteri, A
Repurposing chemotherapy-induced peripheral neuropathy grading
2024 Velasco, R; Argyriou, A; Cornblath, D; Bruna, P; Alberti, P; Rossi, E; Merkies, I; Psimaras, D; Briani, C; Lalisang, R; Schenone, A; Cavaletti, G; Bruna, J
Translation of paclitaxel-induced peripheral neurotoxicity from mice to patients: the importance of model selection
2024 Cavaletti, G; Alberti, P; Canta, A; Carozzi, V; Cherchi, L; Chiorazzi, A; Crippa, L; Marmiroli, P; Meregalli, C; Pozzi, E; Rodriguez-Menendez, V; Steinkühler, C; Licandro, S
Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation
2024 Utkina-Sosunova, I; Chiorazzi, A; de Planell-Saguer, M; Li, H; Meregalli, C; Pozzi, E; Carozzi, V; Canta, A; Monza, L; Alberti, P; Fumagalli, G; Karan, C; Moayedi, Y; Przedborski, S; Cavaletti, G; Lotti, F
Impact of 2021 European Academy of Neurology/Peripheral Nerve Society diagnostic criteria on diagnosis and therapy of chronic inflammatory demyelinating polyradiculoneuropathy variants
2024 De , ; Lorenzo, A; Liberatore, G; Doneddu, P; Manganelli, F; Cocito, D; Briani, C; Fazio, R; Mazzeo, A; Schenone, A; Di , ; Stefano, V; Cosentino, G; Marfia, G; Benedetti, L; Carpo, M; Filosto, M; Antonini, G; Clerici, A; Luigetti, M; Matà, S; Rosso, T; Lucchetta, M; Siciliano, G; Lauria , ; Pinter, G; Cavaletti, G; Inghilleri, M; Cantisani, T; Notturno, F; Ricciardi, D; Habetswallner, F; Spina, E; Peci, E; Salvalaggio, A; Falzone, Y; Strano, C; Gentile, L; Vegezzi, E; Mataluni, G; Cotti , ; Piccinelli, S; Leonardi, L; Romano, A; Nobile-Orazio, E
A phase 2a study investigating the effects of ritlecitinib on brainstem auditory evoked potentials and intraepidermal nerve fiber histology in adults with alopecia areata
2024 Anderson, S; Cavaletti, G; Hood, L; Polydefkis, M; Herrmann, D; Rance, G; King, B; Mcmichael, A; Senna, M; Kim, B; Napatalung, L; Wolk, R; Zwillich, S; Schaefer, G; Gong, Y; Sisson, M; Posner, H
Vincristine Disposition and Neurotoxicity Are Unchanged in Humanized CYP3A5 Mice
2024 Li, Y; Kazuki, Y; Drabison, T; Kobayashi, K; Fujita, K; Xu, Y; Jin, Y; Ahmed, E; Li, J; Eisenmann, E; Baker, S; Cavaletti, G; Sparreboom, A; Hu, S
Electrodiagnostic subtyping in Guillain–Barré syndrome patients in the International Guillain–Barré Outcome Study
2024 Arends, S; Drenthen, J; de Koning, L; van den Bergh, P; Hadden, R; Kuwabara, S; Reisin, R; Shahrizaila, N; Ajroud-Driss, S; Antonini, G; Attarian, S; Balducci, C; Bertorini, T; Brannagan, T; Cavaletti, G; Chao, C; Chavada, G; Dillmann, K; Dimachkie, M; Galassi, G; Gutierrez-Gutierrez, G; Harbo, T; Islam, B; Islam, Z; Katzberg, H; Kusunoki, S; Manganelli, F; Miller, J; Pardo, J; Pereon, Y; Rajabally, Y; Sindrup, S; Stettner, M; Uncini, A; Verhamme, C; Vytopil, M; Waheed, W; Jacobs, B; Cornblath, D; Addington, J; Badrising, U; Barroso, F; Bateman, K; Bella, I; Benedetti, L; van den Berg, B; Bhavaraju-Sanka, R; Briani, C; Buermann, J; Busby, M; Butterworth, S; Casasnovas, C; Chen, S; Claeys, K; Conti, E; Cosgrove, J; Dalakas, M; van Damme, P; Dardiotis, E; Davidson, A; Doets, A; van Doorn, P; Echaniz-Laguna, A; Eftimov, F; Faber, K; Fazio, R; Feasby, T; Fehmi, J; Fokke, C; Fujioka, T; Fulgenzi, E; Garssen, M; Gijsbers, C; Gilchrist, J; Gilhuis, J; Goldstein, J; Gorson, K; Goyal, N; Granit, V; Gutmann, L; Hartung, H; Holt, J; Hsieh, S; Htut, M; Hughes, R; Jerico-Pascual, I; Kaida, K; Karafiath, S; Khoshnoodi, M; Kiers, L; Kleiweg, R; Kokubun, N; Kolb, N; van Koningsveld, R; van der Kooi, A; Kramers, H; Kuitwaard, K; Kwan, J; Ladha, S; Lassen, L; Lawson, V; Lehmann, H; Cejas, L; Leonhard, S; Luijten, L; Lunn, M; Manji, H; Marfia, G; Infante, C; Martin-Aguilar, L; Martinez-Hernandez, E; Mataluni, G; Mattiazzi, M; Mcdermott, C; Meekins, G; Mohammad, Q; Monges, S; de la Tassa, G; Nascimbene, C; Nobile-Orazio, E; Nowak, R; Osei-Bonsu, M; Pelouto, F; Pulley, M; Gutierrez, L; Reddel, S; van der Ree, T; Rinaldi, S; Ripellino, P; Roberts, R; Rojas-Marcos, I; Roodbol, J; Rudnicki, S; Sachs, G; Samijn, J; Santoro, L; Schenone, A; Tous, M; Sheikh, K; Silvestri, N; Sundrup, S; Sommer, C; Stein, B; Stino, A; Thomma, R; Twydell, P; Varrato, J; Vermeij, F; Verschuuren, J; Visser, L; Walgaard, C; Wang, Y; Willison, H; Wirtz, P; van Woerkom, M; Zivkovic, S
Current use of fluid biomarkers as outcome measures in Multiple Sclerosis (MS): a review of ongoing pharmacological clinical trials
2024 Schilke, E; Remoli, G; Funelli, E; Galimberti, M; Fusco, M; Cereda, D; Balducci, C; Frigo, M; Cavaletti, G
Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: the role of nerve excitability testing
2024 Chiorazzi, A; Canta, A; Carozzi, V; Meregalli, C; Pozzi, E; Ballarini, E; Rodriguez-Menendez, V; Marmiroli, P; Cavaletti, G; Alberti, P
Paclitaxel acutely activates ICRAC in sensory neurons: implications for paclitaxel-induced peripheral neuropathy
2024 Delconti, M; Dionisi, M; Ravasenga, T; Romanazzi, T; Riva, B; Lim, D; Gennazzani, A; Meregalli, C; Cavaletti, G; Distasi, C
MORPHOLOGICAL AND METABOLOMIC CHANGES IN PIPN
2024 Bonomo, R; Canta, A; Chiorazzi, A; Carozzi, V; Meregalli, C; Pozzi, E; Alberti, P; Marmiroli, P; Skene, D; Cavaletti, G
PROTEASOME INHIBITORS: IN VITRO MORPHO- FUNCTIONAL CHANGES
2024 Fabbro, V; Malacrida, A; Iseppon, F; Tarasiuk, O; Pero, M; Bartolini, F; Mauri, M; Stanga, S; Cavaletti, G; Meregalli, C
Angiogenesis-Related New Mechanisms for Chemotherapy-Induced Painful Peripheral Neuropathy in the Rat
2024 Carozzi, V; Rodriguez-Menendez, V; Pozzi, E; Canta, A; Chiorazzi, A; Ballarini, E; Alberti, P; Meregalli, C; Cordani, N; Donà, E; Ramazzotti, D; Bravin, A; Tromba, G; Cavaletti, G; Giuliano Zippo, A
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile